Currently, BPC-157 is not authorized for human use as it lacks approval for any indication
Saxenda also contains liraglutide but is used for chronic weight management
Search items included medication-related itemsGLP-1 receptor agonist, GLP-1RA, dual-agonist, and glucagon-like peptide-1 along with cardiovascular outcome-related items major adverse cardiovascular event, myocardial infarction, coronary artery disease, peripheral arterial disease, heart failure, hypertension, and atrial fibrillation. Studies were meticulously screened and included if they reported cardiovascular outcomes related to MACE, myocardial infarction (MI), CAD, PAD, HF, hypertension (HTN), or AF
Replicates, randomization and blinding In vivo studies were performed in male mice that were randomly distributed in groups matched for genotype, age, body weight and body composition (fat and lean tissue mass)